Payment overview · 2025
General Payments
$383.74
18 reported records · 11 companies
Healthcare provider profile · identity verified
Vivek Khetpal, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease · DURANT, OK · NPI 1154394823
Verified facts
What the public records show
CMS Open Payments records show Vivek Khetpal, M.D. received $383.74 in general payments during 2025 across 18 reported records.
Impulse Dynamics (USA) Inc. accounted for 19.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 13 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rexulti.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 100 claims for Ozempic by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 54 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Impulse Dynamics (USA) Inc. | Unresolved — no canonical attribution shown | $74.93 | 19.5% | 2 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $48.04 | 12.5% | 2 | 2025 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $43.06 | 11.2% | 3 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $43.05 | 11.2% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $34.18 | 8.9% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $29.98 | 7.8% | 2 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $27.29 | 7.1% | 1 | 2025 |
| VIVUS LLC | Unresolved — no canonical attribution shown | $23.14 | 6.0% | 1 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $22.18 | 5.8% | 1 | 2025 |
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $19.34 | 5.0% | 1 | 2025 |
| Vital Connect, Inc | Unresolved — no canonical attribution shown | $18.55 | 4.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $383.74 | 18 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Optimizer Normalized: optimizer |
Device | Impulse Dynamics (USA) Inc. | $74.93 | 2 | 2025 |
Source payment records
|
|||||
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $43.06 | 3 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $34.18 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $27.29 | 1 | 2025 |
Source payment records
|
|||||
| AVEIR Normalized: aveir |
Device | Abbott Laboratories | $24.69 | 1 | 2025 |
Source payment records
|
|||||
| PRESSUREWIRE Normalized: pressurewire |
Device | Abbott Laboratories | $23.35 | 1 | 2025 |
Source payment records
|
|||||
| QSYMIA Normalized: qsymia |
Drug | VIVUS LLC | $23.14 | 1 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $21.99 | 1 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $21.06 | 1 | 2025 |
Source payment records
|
|||||
| MYNX CONTROL Normalized: mynx control |
Device | CORDIS US CORP. | $19.34 | 1 | 2025 |
Source payment records
|
|||||
| VITALPATCH RTM Normalized: vitalpatch rtm |
Device | Vital Connect, Inc | $18.55 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $15.96 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $14.02 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 100 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 54 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
100 | 23 |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
54 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1098 | 208 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1090 | 342 |
| Gabapentin | Gabapentin | 849 | 204 |
| Clopidogrel | Clopidogrel Bisulfate | 811 | 258 |
| Eliquis | Apixaban | 676 | 140 |
| Losartan Potassium | Losartan Potassium | 576 | 174 |
| Pantoprazole Sodium | Pantoprazole Sodium | 522 | 156 |
| Potassium Chloride | Potassium Chloride | 495 | 132 |
| Furosemide | Furosemide | 485 | 141 |
| Metoprolol Succinate | Metoprolol Succinate | 484 | 170 |
| Amlodipine Besylate | Amlodipine Besylate | 452 | 150 |
| Levothyroxine Sodium | Levothyroxine Sodium | 446 | 109 |
| Tamsulosin Hcl | Tamsulosin Hcl | 376 | 121 |
| Omeprazole | Omeprazole | 371 | 107 |
| Metoprolol Tartrate | Metoprolol Tartrate | 340 | 117 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 326 | 104 |
| Carvedilol | Carvedilol | 317 | 88 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 317 | 93 |
| Spironolactone | Spironolactone | 292 | 104 |
| Farxiga | Dapagliflozin Propanediol | 277 | 67 |
| Lisinopril | Lisinopril | 266 | 84 |
| Torsemide | Torsemide | 258 | 75 |
| Ropinirole Hcl | Ropinirole Hcl | 256 | 68 |
| Metformin Hcl | Metformin Hcl | 230 | 70 |
| Trazodone Hcl | Trazodone Hcl | 229 | 54 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 215 | 60 |
| Memantine Hcl | Memantine Hcl | 214 | 45 |
| Sertraline Hcl | Sertraline Hcl | 194 | 47 |
| Januvia | Sitagliptin Phosphate | 189 | 48 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 187 | 64 |
| Ranolazine Er | Ranolazine | 182 | 55 |
| Tramadol Hcl | Tramadol Hcl | 181 | 80 |
| Nitroglycerin | Nitroglycerin | 178 | 109 |
| Xarelto | Rivaroxaban | 174 | 50 |
| Allopurinol | Allopurinol | 171 | 57 |
| Montelukast Sodium | Montelukast Sodium | 166 | 46 |
| Amiodarone Hcl | Amiodarone Hcl | 156 | 41 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 156 | 61 |
| Tizanidine Hcl | Tizanidine Hcl | 152 | 34 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 148 | 40 |
| Clonidine | Clonidine | 144 | 44 |
| Duloxetine Hcl | Duloxetine Hcl | 142 | 42 |
| Pregabalin | Pregabalin | 142 | 61 |
| Prednisone | Prednisone | 136 | 69 |
| Pravastatin Sodium | Pravastatin Sodium | 133 | 45 |
| Cefuroxime | Cefuroxime Axetil | 130 | 106 |
| Clonidine Hcl | Clonidine Hcl | 126 | 40 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 125 | 20 |
| Methylprednisolone | Methylprednisolone | 124 | 101 |
| Sucralfate | Sucralfate | 121 | 32 |
| Mirtazapine | Mirtazapine | 118 | 24 |
| Buspirone Hcl | Buspirone Hcl | 117 | 28 |
| Methocarbamol | Methocarbamol | 114 | 41 |
| Ondansetron Hcl | Ondansetron Hcl | 114 | 49 |
| Quetiapine Fumarate | Quetiapine Fumarate | 111 | 29 |
| Levetiracetam | Levetiracetam | 110 | 20 |
| Warfarin Sodium | Warfarin Sodium | 110 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 109 | 45 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 109 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 106 | 33 |
| Clonazepam | Clonazepam | 100 | 39 |
| Ozempic | Semaglutide | 100 | 23 |
| Meloxicam | Meloxicam | 99 | 37 |
| Jardiance | Empagliflozin | 94 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 92 | 31 |
| Mounjaro | Tirzepatide | 89 | 24 |
| Donepezil Hcl | Donepezil Hcl | 85 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 82 | 29 |
| Topiramate | Topiramate | 80 | 12 |
| Doxepin Hcl | Doxepin Hcl | 76 | 16 |
| Nifedipine Er | Nifedipine | 76 | 25 |
| Hydralazine Hcl | Hydralazine Hcl | 75 | 21 |
| Alprazolam | Alprazolam | 74 | 24 |
| Temazepam | Temazepam | 74 | 27 |
| Lamotrigine | Lamotrigine | 73 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 73 | 29 |
| Ondansetron Odt | Ondansetron | 71 | 42 |
| Lactulose | Lactulose | 70 | 25 |
| Estradiol | Estradiol | 68 | 15 |
| Famotidine | Famotidine | 68 | 18 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 68 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 68 | 21 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 67 | 11 |
| Cephalexin | Cephalexin | 66 | 49 |
| Digoxin | Digoxin | 66 | 20 |
| Ibuprofen | Ibuprofen | 65 | 18 |
| Finasteride | Finasteride | 64 | 22 |
| Labetalol Hcl | Labetalol Hcl | 63 | 19 |
| Prasugrel Hcl | Prasugrel Hcl | 63 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 63 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 62 | 54 |
| Oxycodone Hcl | Oxycodone Hcl | 61 | suppressed |
| Atenolol | Atenolol | 60 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 58 | 43 |
| Oxybutynin Chloride | Oxybutynin Chloride | 56 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 56 | 18 |
| Risperidone | Risperidone | 55 | 11 |
| Clindamycin Hcl | Clindamycin Hcl | 54 | 47 |
| Rexulti | Brexpiprazole | 54 | suppressed |
| Entresto | Sacubitril/Valsartan | 53 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 53 | 17 |
| Fluconazole | Fluconazole | 52 | 31 |
| Levofloxacin | Levofloxacin | 52 | 41 |
| Doxycycline Hyclate | Doxycycline Hyclate | 50 | 45 |
| Hydrochlorothiazide | Hydrochlorothiazide | 49 | 14 |
| Primidone | Primidone | 49 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 47 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 46 | 11 |
| Ezetimibe | Ezetimibe | 45 | 16 |
| Megestrol Acetate | Megestrol Acetate | 45 | 21 |
| Constulose | Lactulose | 43 | 25 |
| Simvastatin | Simvastatin | 43 | 16 |
| Trulicity | Dulaglutide | 42 | suppressed |
| Azithromycin | Azithromycin | 41 | 36 |
| Baclofen | Baclofen | 41 | 13 |
| Prazosin Hcl | Prazosin Hcl | 41 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 40 | suppressed |
| Hydrocortisone | Hydrocortisone | 39 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 38 | suppressed |
| Lidocaine | Lidocaine | 38 | suppressed |
| Nystatin | Nystatin | 38 | 24 |
| Linzess | Linaclotide | 37 | 12 |
| Cartia Xt | Diltiazem Hcl | 36 | 20 |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 35 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 35 | suppressed |
| Cilostazol | Cilostazol | 33 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 33 | suppressed |
| Vraylar | Cariprazine Hcl | 32 | 12 |
| Celecoxib | Celecoxib | 31 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 31 | 20 |
| Vancomycin Hcl | Vancomycin Hcl | 30 | suppressed |
| Enulose | Lactulose | 29 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 17 |
| Midodrine Hcl | Midodrine Hcl | 28 | 11 |
| Novolin R | Insulin Regular, Human | 28 | suppressed |
| Aripiprazole | Aripiprazole | 27 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 27 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 27 | 11 |
| Venlafaxine Hcl | Venlafaxine Hcl | 27 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 26 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 24 | suppressed |
| Sotalol | Sotalol Hcl | 24 | suppressed |
| Metolazone | Metolazone | 23 | 11 |
| Terazosin Hcl | Terazosin Hcl | 23 | suppressed |
| Bupropion Xl | Bupropion Hcl | 22 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 22 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 22 | suppressed |
| Synthroid | Levothyroxine Sodium | 22 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 22 | 13 |
| Alendronate Sodium | Alendronate Sodium | 21 | suppressed |
| Exemestane | Exemestane | 21 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 21 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 20 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 20 | suppressed |
| Myrbetriq | Mirabegron | 20 | suppressed |
| Olanzapine | Olanzapine | 20 | suppressed |
| Premarin | Estrogens, Conjugated | 20 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 20 | suppressed |
| Verapamil Er | Verapamil Hcl | 20 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Mupirocin | Mupirocin | 19 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 19 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 18 | suppressed |
| Glipizide | Glipizide | 18 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 18 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 18 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Amantadine | Amantadine Hcl | 16 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 16 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 12 |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 14 | 11 |
| Minoxidil | Minoxidil | 14 | suppressed |
| Ofloxacin | Ofloxacin | 14 | suppressed |
| Xifaxan | Rifaximin | 14 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Glucagen | Glucagon | 13 | suppressed |
| Levemir Flexpen | Insulin Detemir | 13 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 13 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 12 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Levemir | Insulin Detemir | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Travoprost | Travoprost | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 11 | suppressed |
| Linezolid | Linezolid | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $383.74 · 18 records | Impulse Dynamics (USA) Inc. | AVEIR, Cologuard Collection Kit, LifeVest, MYNX CONTROL, Optimizer, Ozempic, PRESSUREWIRE, QSYMIA, REPATHA, REXULTI, The Cologuard Plus Collection Kit, VITALPATCH RTM, Wegovy | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error